DYNABLAST PASTE 0.5CC 10.210.1050

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,06,07 report with the FDA on 2014-12-01 for DYNABLAST PASTE 0.5CC 10.210.1050 manufactured by Keystone Dental Inc..

Event Text Entries

[20326464] The clinician reported that a male patient, who has been under his care for 10 years, underwent a tooth extraction procedure for dental site 30. After the atraumatic extraction was completed on site 30, the site was grafted with dynablast from lot # 140018 and the site was covered with gelfoam and sutured. The patient then became flush and experienced heart palpitations, at which time he was closely monitored. The patient went to the restroom and when he did not return in a timely manner, the staff followed up to find the patient unconscious on the floor. The staff initiated a 911 call and the patient was transported to the emergency room by ambulance. The patient was treated and released and the graft remained in place. The clinician followed up with the patient via telephone and was told by the patient that he had consulted with his primary care person and that they suspected he had a reaction to the novocaine and prescribed him an epipen. The primary care office recommended that the patient return to the original clinician for a small dose of novocaine to either confirm or rule it out as the source of the incident. The patient received a small dose of novocaine without any side effects.
Patient Sequence No: 1, Text Type: D, B5


[20506149] (b)(4). This occurrence was communicated to the contract manufacturer (b)(4) and a review of the manufacturing records is underway, a follow-up report detailing the manufacturing findings will follow. No additional complaints from this list were identified during a review of keystone complaints database. This patient has no known allergies. Polymyxin sulfate b, bacitracin, gentimycin and iodine are used in upstream processing and trace amounts may remain in the final product. Consequently the dynablast ifu lists contraindications for patients with known sensitivities to these processing agents. A copy of the dynablast ifu was forwarded to the clinician. The root cause of this occurrence remains inconclusive at this time. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3005990499-2014-00001
MDR Report Key4308546
Report Source05,06,07
Date Received2014-12-01
Date of Report2014-12-01
Date of Event2014-08-28
Device Manufacturer Date2014-06-01
Date Added to Maude2014-12-10
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationDENTIST
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactLIZ CACCIOLA
Manufacturer Street144 MIDDLESEX TURNPIKE
Manufacturer CityBURLINGTON MA 01803
Manufacturer CountryUS
Manufacturer Postal01803
Manufacturer Phone7813283390
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameDYNABLAST PASTE 0.5CC
Product CodeNUN
Date Received2014-12-01
Catalog Number10.210.1050
Lot Number140871
Device Expiration Date2016-06-30
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerKEYSTONE DENTAL INC.
Manufacturer AddressBURLINGTON MA US


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization 2014-12-01

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.